BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Anticancer prodrugs
,
Phenobarbital
,
rs4950928
,
DNMT1
,
Angiogenesis
,
Ischemia
,
Pancreas
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
cdk inhibitors
Summary
General Info
Curated Studies
Most Correlated Studies
Peripheral blood mononuclear, DU145, and HCT116 cells treated with R547 CDK inhibitor
A2780 and MCF7 cancer cell lines treated with CDK, HSP90, and topoisomerase inhibitors
B cell lymphoma VAL and OCI-LY3 cells treated with CDK-9 inhibitor AZ5576 compound
T cell acute lymphoblastic leukemia MOLT4 cells treated with cyclin-dependent kinase inhibitors
Clival chordoma UM-Chor1 cells treated with THZ1 or actinomycin D
Explore Curated Studies Results
Literature
Most Relevant Literature
An Overview of CDK Enzyme Inhibitors in Cancer Therapy.
Emerging approaches to CDK inhibitor development, a structural perspective.
Pharmacological relevance of CDK inhibitors in Alzheimer's disease.
Integration of Postoperative Radiation Therapy with Cyclin-Dependent Kinase (CDK) Inhibitors.
Systematic screening identifies ABCG2 as critical factor underlying synergy of kinase inhibitors wit…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Evaluation of Skin Health and Quality of Life in Patients Receiving Anti-PD1/PDL1/CTLA4 or Cyclin-de…
Evaluation of Geriatric Questionnaires to Predict Toxicities of CDK 4/6 Inhibitors in Older Breast C…
Study of Ribociclib With Everolimus + Exemestane in HR+ HER2- Locally Advanced/Metastatic Breast Can…
Study of an Oral Cdk Inhibitor Administered With an Oral BRAF Inhibitor in Patients With Advanced or…
A Phase II Study of AT7519M, a CDK Inhibitor, in Patients With Relapsed and/or Refractory Chronic Ly…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ